Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly and Novo Nordisk are competing for ...

The demand for obesity drugs in India is surging as Eli Lilly and Novo Nordisk compete. A Pakistani startup sends prosthetics ...

The health sector is witnessing notable developments, including the rising demand for obesity drugs in India as Eli Lilly and ...

Eli LillyDemand for weight-loss drugs in India has shot up.And rivals Novo Nordisk and Eli Lilly are battling for market ...

Incidence of obesity and diabetes is rising in India, the world's most populous country, which also ranks among the worst ...

The demand for weight-loss medications is rapidly increasing in India, with competitors Eli Lilly and Novo Nordisk vying for ...

Pharmarack is part of Inc42’s 42 Fellowship – a year-long fellowship programme for India’s top growing and upcoming startups with the aim to build a close-knit community who can help each ...

Pharmarack Technologies' revenue model is subscription-based, where customers can either opt for a flat fee that can be paid on a monthly basis, or they can opt for the pay-per-use model.

SINGAPORE--(BUSINESS WIRE)--Informatica (NYSE: INFA), an enterprise cloud data management leader, today announced that Pharmarack, India’s largest commerce-to-insights technology company, has ...

Just two days after Novo Nordisk launched Wegovy (semaglutide 2.4 mg) in India, Eli Lilly received regulatory approval for ...

The Karnataka Chemists and Druggists Association (KCDA) is concerned over Pharmarack’s recent move in which it has communicated to all the stockists in the state insisting them to order directly from ...

Pune-based Pharmarack has raised $3 Mn in a Series A funding round from IvyCap Ventures. As part of the deal, the IvyCap Ventures’ founder and managing partner Vikram Singh will join the ...